NKG2-A Antibodies

Santa Cruz Biotechnology offers a broad range of NKG2-A monoclonal antibodies for immunology and cell biology research. NKG2-A monoclonal antibodies perform effectively in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKG2-A, a member of the NKG2 family of receptors, plays a crucial role in regulating immune responses by inhibiting the activation of natural killer (NK) cells and T cells. NKG2-A maintains immune tolerance and prevents autoimmunity, making it a significant target for research in cancer immunotherapy and infectious diseases. Understanding NKG2-A function can provide insights into immune evasion by tumors and lead to the development of novel therapeutic strategies. Researchers worldwide rely on NKG2-A monoclonal antibodies to explore immune system regulation and its impact on disease progression. Current studies focusing on NKG2-A have revealed promising applications in cancer treatment and autoimmune disease management. Santa Cruz Biotechnology monoclonal antibodies for NKG2-A enable researchers to advance scientific understanding of immune system regulation and contribute to the development of innovative therapeutic approaches.